Compare · LMDX vs TKNO
LMDX vs TKNO
Side-by-side comparison of LumiraDx Limited (LMDX) and Alpha Teknova Inc. (TKNO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LMDX and TKNO operate in Biotechnology: In Vitro & In Vivo Diagnostic Substances (Health Care), so they compete in similar markets.
- LMDX is the larger of the two at $2.23B, about 5.6x TKNO ($400.5M).
- TKNO has hit the wire 6 times in the past 4 weeks while LMDX has been quiet.
- TKNO has more recent analyst coverage (9 ratings vs 4 for LMDX).
- Company
- LumiraDx Limited
- Alpha Teknova Inc.
- Price
- $0.02-53.80%
- $7.46+1.43%
- Market cap
- $2.23B
- $400.5M
- 1M return
- -
- +54.35%
- 1Y return
- -
- +63.13%
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 0
- 6
- Recent ratings
- 4
- 9
Latest LMDX
- SEC Form SC 13G/A filed by LumiraDx Limited (Amendment)
- SEC Form SC 13G/A filed by LumiraDx Limited (Amendment)
- SEC Form 6-K filed by LumiraDx Limited
- 12 Health Care Stocks Moving In Monday's After-Market Session
- Dow Surges Over 100 Points; Commercial Metals Posts Upbeat Q1 Results
- Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- LumiraDx shares are trading lower after the company announced its securities will be suspended from trading on Nasdaq at the open of business tomorrow.
- 12 Health Care Stocks Moving In Monday's Intraday Session
- Crude Oil Falls Sharply; Ambrx Biopharma Shares Spike Higher
- US Stocks Mixed; Nasdaq Jumps Over 100 Points
Latest TKNO
- Alpha Teknova upgraded by BTIG Research with a new price target
- SEC Form 10-Q filed by Alpha Teknova Inc.
- Alpha Teknova Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Teknova Reports Second Quarter 2026 Financial Results
- Teknova Launches Build-Tek™, a Proprietary AI Reagent Assistant That Allows Customers to Configure Complex Custom Product Requests in Minutes
- Roth Capital initiated coverage on Alpha Teknova with a new price target
- Teknova to Report Second Quarter 2026 Financial Results on August 5, 2026
- Director Demski Martha J disposed of 12,000 shares and acquired 12,000 shares, closing all direct ownership in the company (SEC Form 4)
- SEC Form 4 filed by Director Vos Alexander
- SEC Form 4 filed by Director Robertson Brett